September 15, 2021
Article
Though efficacy waned over months, protection from symptomatic and severe COVID-19 remained significant, with no new adverse event risks observed.
September 08, 2021
A neighborhood-level assessment of major cities show areas impacted the most by historic COVID-19 deaths are significantly less vaccinated.
August 31, 2021
New Imbokodo findings show a 4-dose regimen was only about 25% effective in preventing HIV in at-risk women, hindering progress for the vaccine.
August 26, 2021
An Israel study estimates vaccinated persons' risk of side effects including myocarditis, relative to the risk brought on by SARS-CoV-2 infection.
August 25, 2021
The submission comes day after BNT162b2 became the first fully approved COVID-19 vaccine by the FDA.
August 24, 2021
Video
David Weber, MD, MPH, explains what portion of the population may buy into the newly approved Pfizer-BioNTech vaccine.
August 23, 2021
The full approval for BNT162b2 will afford physicians greater prescribing capability, and will likely drive workplace vaccine mandates.
August 17, 2021
The Biden administration reportedly hopes for FDA-authorized booster doses for the adult general population in the next month.
August 16, 2021
The US is targeting a possible Fall rollout of publicly available doses, yet experts debate their current necessity.
August 12, 2021
An England study shows the Pfizer-BioNTech and AstraZeneca vaccines remain effective in reducing symptomatic disease risk.
